CHEN W , ZHENG R , BAADE P D , et al . Cancer statistics in China,2015 [J ] . CA Cancer J Clin , 2016 , 66 ( 1 ): 115 - 132 .

NORDLING C O . A new theory on cancerinducing mechanism [J ] . British Journal of Cancer , 1953 , 7 ( 1 ): 68 - 72 .

ROZHOK A I , DEGREGORI J . Toward an evolutionary model of cancer:Considering the mechanisms that govern the fate of somatic mutations [J ] . Proceedings of the National Academy of Sciences of the United States of America , 2015 , 112 ( 29 ): 8914 - 8921 .

HANAHAN D , WEINBERG R A . Hallmarks of cancer:the next generation [J ] . Cell , 2011 , 144 ( 5 ): 646 - 674 .

FISHER R , PUSZTAI L , SWANTON C . Cancer heterogeneity:implications for targeted therapeutics [J ] . British Journal of Cancer , 2013 , 108 ( 3 ): 479 - 485 .

SWANTON C . Intratumor heterogeneity:evolution through space and time [J ] . Cancer Research , 2012 , 72 ( 19 ): 4875 - 4882 .

YATES L R , CAMPBELL P J . Evolution of the cancer genome [J ] . Nature Reviews Genetics , 2012 , 13 ( 11 ): 795 - 806 .

COLLINS F S , H Varmus . A new initiative on precision medicine [J ] . New England Journal of Medicine , 2015 , 372 ( 9 ): 793 - 795 .

CYRANOSKI D . China embraces precision medicine on a massive scale [J ] . Nature , 2016 , 529 ( 7584 ): 9 - 10 .

LOCKHART D J , WINZELER E A . Genomics,gene expression and DNA arrays [J ] . Nature , 2000 , 405 ( 6788 ): 827 - 836 .

GLIGORIJEVIC V,MALOD-DOGNIN N , PRZULJ N . Integrative methods for analysing big data in precision medicine [J ] . Proteomics , 2015 , 16 ( 5 ):7.

MARGOLIN A A , NEMENMAN I , BASSO K , et al . ARACNE:an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context [J ] . BMC Bioinformatics , 2006 , 7 ( 2 ):S7

LEFEBVRE C , RAJBHANDARI P , ALVAREZ M J , et al . A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers [J ] . Molecular Systems Biology , 2010 , 6 ( 1 ):377.

CHEN J C , ALVAREZ M , TALOS F , et al . Identification of causal genetic drivers of human disease through systems-level analysis of regulatory networks [J ] . Cell , 2014 , 159 ( 2 ): 402 - 414 .

DEHMER M , MUELLER L A , EMMERTSTREIB F . Quantitative network measures as biomarkers for classifying prostate cancer disease states:a systems approach to diagnostic biomarkers [J ] . PLos One , 2013 , 8 ( 11 ):e77602.

LAMB J , CRAWFORD E D , PECK D , et al . The connectivity map:using geneexpression signatures to connect small molecules,genes,and disease [J ] . Science , 2006 , 313 ( 5795 ): 1929 - 1935 .

SUBRAMANIAN A , TAMAYO P , MOOTHA V K , et al . Gene set enrichment analysis:a knowledge-based approach for interpreting genome-wide expression profiles [J ] . Proceedings of the National Academy of Sciences , 2005 , 102 ( 43 ): 15545 - 15550 .

QU X A , RAJPAL D K . Applications of connectivity map in drug discovery and development [J ] . Drug Discovery Today , 2012 , 17 ( 23-24 ): 1289 - 1298 .

CULHANE A C,SCHRÖDER M S , SULTANA R , et al . GeneSigDB:a manually curated database and resource for analysis of gene expression signatures [J ] . Nucleic Acids Research , 2012 , 40 ( Database Issue ): 1060 - 1066 .

HOLLANDER M , WOLFE D A , CHICKEN E . Nonparametric statistical methods [M ] // Biostatistics and Microbiology:A Survival Manual . New York : Springer New York , 2011 : 121 - 162 .

PECK D , CRAWFORD E D , ROSS K N , et al . A method for high-throughput gene expression signature analysis [J ] . Genome Biology , 2006 , 7 ( 7 ): 91 - 96 .

CHEN Y , LI Y , NARAYAN R , et al . Gene expression inference with deep learning [J ] . Bioinformatics , 2016 , 32 ( 12 ): 1832 - 1839 .

WANG G , YE Y , YANG X , et al . Expression-based in silico screening of candidate therapeutic compounds for lung adenocarcinoma [J ] . PLoS One , 2011 , 6 ( 1 ):e14573.

SIAVELIS J C , BOURDAKOU M M , ATHANASIADIS E I , et al . Bioinformatics methods in drug repurposing for Alzheimer's disease [J ] . Briefings in Bioinformatics , 2015 : 1 - 14 .

WILLIAMS G . SPIEDw:a searchable platform-independent expression database web tool [J ] . BMC Genomics , 2013 , 14 ( 1 ): 1 - 6 .

ZHANG S D , GANT T W . sscMap:an extensible Java application for connecting small-molecule drugs using gene-expression signatures [J ] . BMC Bioinformatics , 2009 , 10 ( 1 ):236

GILLET J P , ANDERSEN J B , MADIGAN J P , et al . A gene expression signature associated with overall survival in patients with hepatocellular carcinoma suggests a new treatment strategy [J ] . Molecular Pharmacology , 2016 , 89 ( 2 ): 263 - 272 .

VENUGOPAL C , HALLETT R , VORA P , et al . Pyrvinium targets CD133 in human glioblastoma brain tumor-initiating cells [J ] . Clinical Cancer Research , 2015 , 21 ( 23 ): 5324 - 5337 .

LEE W Y , LEE W T , CHENG C H , et al . Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1 [J ] . Oncotarget , 2015 , 6 ( 29 ): 27580 - 27595 .

CHURCHMAN M L , LOW J , QU C , et al . Efficacy of retinoids in IKZF1mutated BCR-ABL1 acute lymphoblastic leukemia [J ] . Cancer Cell , 2015 , 28 ( 3 ): 343 - 356 .

WEN Q,O'REILLY P , DUNNE P D , et al . Connectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapies [J ] . Bmc Systems Biology , 2015 , 9 ( 5 ): 1 - 11 .

FARIA C C , SAMEER A , MACK S C , et al . Identification of alsterpaullone as a novel small molecule inhibitor to target group 3 medulloblastoma [J ] . Oncotarget , 2015 , 6 ( 25 ): 21718 - 21729 .

VASCONCELLOS J F D , LEAL P C , BHASIN M K , et al . SB225002 induces cell death and cell cycle arrest in acute lymphoblastic leukemia cells through the activation of GLIPR1 [J ] . Plos One , 2015 , 10 ( 8 ):19.

PULVINO M , CHEN L , OLEKSYNET D , et al . Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline [J ] . Oncotarget , 2015 , 6 ( 17 ): 14796 - 14813 .

LIU X , YANG X , CHEN X , et al . Expression profiling identifies bezafibrate as potential therapeutic drug for lung adenocarcinoma [J ] . Journal of Cancer , 2015 , 6 ( 12 ): 1214 - 1221 .

ZHUO W , ZHANG L , ZHU Y , et al . Valproic acid,an inhibitor of class I histone deacetylases,reverses acquired erlotinibresistance of lung adenocarcinoma cells:a connectivity mapping analysis and an experimental study [J ] . American Journal of Cancer Research , 2015 , 5 ( 7 ): 2202 - 2211 .

CAO C , GAO R , ZHANG M , et al . Role of LKB1-CRTC1 on glycosylated COX-2 and response to COX-2 inhibition in lung cancer [J ] . Jnci Journal of the National Cancer Institute , 2015 , 107 ( 1 ):358.

VAN N V,SCHÖLCH S , ISKAR M , et al . Novel drug candidates for the treatment of metastatic colorectal cancer through global inverse gene-expression profiling [J ] . Cancer Research , 2014 , 74 ( 20 ): 5690 - 5699 .

KIM J , VASU V T , MISHRA R , et al . Bioinformatics-driven discovery of rational combination for overcoming EGFR-mutant lung cancer resistance to EGFR therapy [J ] . Bioinformatics , 2014 , 30 ( 17 ): 2393 - 2398 .

ZERBINI L F , BHASIN M K , VASCONCELLOS J F D , et al . Computational repositioning and preclinical validation of pentamidine for renal cell cancer [J ] . Molecular Cancer Therapeutics , 2014 , 13 ( 7 ): 1929 - 1941 .

GARDNER E E , CONNIS N , POIRIER J T , et al . Rapamycin rescues ABT-737 efficacy in small cell lung cancer [J ] . Cancer Research , 2014 , 74 ( 10 ): 2846 - 2856 .

CHOI Y E , BATTELLI C , WATSON J , et al . Sublethal concentrations of 17AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cells [J ] . Oncotarget , 2014 , 5 ( 9 ): 2678 - 2687 .

CHUNG F H , CHIANG Y R , TSENG A L , et al . Functional module connectivity map (FMCM):a framework for searching repurposed drug compounds for systems treatment of cancer and an application to colorectal adenocarcinoma [J ] . PLos One , 2014 , 9 ( 1 ):e86299.

HUANG C H , CHANG M H , LIN Y J , et al . Drug repositioning discovery for early- and late-stage non-small-cell lung cancer [J ] . Biomed Research International , 2014 ( 1 ): 309 - 322 .

DING H , MCDONALD J S , YUN S , et al . Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells [J ] . Haematologica , 2014 , 99 ( 1 ): 60 - 69 .

WANG B S , LIU Z , SUN S L , et al . Identification of genes and candidate agents associated with pancreatic cancer [J ] . Tumour Biology:the Journal of the International Society for Oncodevelopmental Biology and Medicine , 2014 , 35 ( 1 ): 81 - 88 .

RAMSEY J M , KETTYLE L M J , SHARPE D J , et al . Entinostat prevents leukemia maintenance in a collaborating oncogenedependent model of cytogenetically normal acute myeloid leukemia [J ] . Stem Cells , 2013 , 31 ( 7 ): 1434 - 1445 .

MA C , TANG K , LIU Q , et al . Calmodulin as a potential target by which berberine induces cell cycle arrest in human hepatoma Bel7402 cells [J ] . Chemical Biology & Drug Design , 2013 , 81 ( 6 ): 775 - 783 .

BAI J P , ALEKSEYENKO A V , STATNIKOV A , et al . Strategic applications of gene expression:from drug discovery/development to bedside [J ] . Aaps Journal , 2013 , 15 ( 2 ): 427 - 437 .